Figure 4.

Interfering at an early stage in an immune response (i.e. T cell activation) is likely to block subsequent inflammatory events mediated by several different effector cells. APC, antigen-presenting cell; IL, interleukin; TNF, tumour necrosis factor.

Malmström et al. Arthritis Research & Therapy 2005 7(Suppl 2):S15-S20   doi:10.1186/ar1505